Aveanna Healthcare (NASDAQ:AVAH) Given New $15.00 Price Target at Truist Financial

Aveanna Healthcare (NASDAQ:AVAH) had its price objective hoisted by analysts at Truist Financial from $11.00 to $15.00 in a report released on Monday,Benzinga reports. The firm currently has a “hold” rating on the stock. Truist Financial’s target price indicates a potential upside of 9.53% from the company’s previous close.

Other analysts also recently issued reports about the stock. Weiss Ratings reissued a “hold (c+)” rating on shares of Aveanna Healthcare in a research note on Thursday, July 2nd. Wall Street Zen cut Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 15th. BMO Capital Markets lifted their price target on Aveanna Healthcare from $10.00 to $14.00 and gave the stock an “outperform” rating in a research note on Friday, August 14th. Barclays increased their price objective on Aveanna Healthcare from $9.00 to $9.50 and gave the company an “overweight” rating in a research note on Thursday, July 9th. Finally, UBS Group upped their price target on shares of Aveanna Healthcare from $8.00 to $13.00 and gave the company a “neutral” rating in a report on Friday, August 14th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $12.89.

Aveanna Healthcare Price Performance

Shares of AVAH traded up $0.54 during midday trading on Monday, hitting $13.70. 2,240,278 shares of the company traded hands, compared to its average volume of 1,784,007. The firm has a market cap of $2.99 billion, a P/E ratio of 11.13, a PEG ratio of 0.92 and a beta of 1.90. Aveanna Healthcare has a one year low of $5.93 and a one year high of $13.98. The stock has a 50-day moving average of $9.58 and a 200-day moving average of $7.92. The company has a debt-to-equity ratio of 4.47, a current ratio of 1.16 and a quick ratio of 1.16.

Aveanna Healthcare (NASDAQ:AVAH) last announced its earnings results on Thursday, August 13th. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.05. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. The company had revenue of $670.48 million during the quarter, compared to analyst estimates of $638.61 million. As a group, sell-side analysts predict that Aveanna Healthcare will post 0.68 EPS for the current fiscal year.

Insider Activity at Aveanna Healthcare

In other news, major shareholder J.H. Whitney Equity Partners V sold 2,419,035 shares of Aveanna Healthcare stock in a transaction dated Tuesday, June 30th. The shares were sold at an average price of $8.01, for a total transaction of $19,376,470.35. Following the sale, the insider owned 10,112,123 shares of the company’s stock, valued at approximately $80,998,105.23. The trade was a 19.30% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, major shareholder Robert M. Williams, Jr. sold 3,000,000 shares of the stock in a transaction dated Tuesday, June 30th. The stock was sold at an average price of $8.01, for a total transaction of $24,030,000.00. Following the completion of the transaction, the insider directly owned 190,130 shares of the company’s stock, valued at approximately $1,522,941.30. The trade was a 94.04% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 31,180,664 shares of company stock worth $214,607,160 over the last quarter. Corporate insiders own 5.30% of the company’s stock.

Institutional Investors Weigh In On Aveanna Healthcare

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. BlackRock Inc. bought a new position in shares of Aveanna Healthcare during the second quarter valued at approximately $63,504,000. Vanguard Group Inc. raised its stake in Aveanna Healthcare by 38.0% during the fourth quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock valued at $45,564,000 after buying an additional 1,535,351 shares during the last quarter. Millennium Management LLC boosted its holdings in Aveanna Healthcare by 1,007.1% in the fourth quarter. Millennium Management LLC now owns 1,114,717 shares of the company’s stock worth $9,107,000 after acquiring an additional 1,014,030 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Aveanna Healthcare in the second quarter worth $7,881,000. Finally, Nuveen LLC increased its holdings in shares of Aveanna Healthcare by 135.9% during the fourth quarter. Nuveen LLC now owns 1,571,308 shares of the company’s stock valued at $12,838,000 after acquiring an additional 905,316 shares in the last quarter. 87.96% of the stock is owned by hedge funds and other institutional investors.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.